The Department of Health and Social Care has appointed management consultancy Deloitte and law firm Addleshaw Goddard as technical advisers to develop a public-private partnership model for financing the government's neighbourhood health centre programme. The two firms have been awarded contracts worth approximately £3 million each to design the financial and legal structures through which the majority of 250 planned centres are expected to be built by 2030.
The government's intention is that roughly 80 per cent of new-build neighbourhood health centres will be financed through private partnerships rather than direct public funding. The remaining 20 per cent will receive conventional capital allocation. That split reflects the constraints on public capital expenditure rather than a preference for private finance as a matter of policy principle. The NHS estate carries an estimated £14 billion maintenance backlog, and the Treasury's appetite for additional capital commitments within that context is limited. Private investment is being pursued as the mechanism through which the programme can proceed at the pace ministers have committed to publicly.
The work commissioned from Deloitte and Addleshaw Goddard covers financial modelling, the design of partnership structures, and an assessment of the value for money of private capital against traditional government borrowing. The firms may also provide support during the procurement phase, assisting the department in matching private investors with individual local NHS projects. That role would extend their involvement beyond advisory work into the active structuring of transactions, which carries its own implications for how the department manages conflicts of interest and maintains independence of judgement.
The department has developed the model alongside the New Infrastructure and Strategic Transformation Authority and has stated that the approach is designed to incorporate lessons from the NHS Local Improvement Finance Trust and Private Finance Initiative schemes introduced during the 1990s and 2000s. Those programmes delivered infrastructure but generated long-term contractual obligations that proved inflexible and, in a number of cases, financially burdensome for the trusts that inherited them. Some NHS organisations are still meeting PFI repayments on contracts signed decades ago, and the costs of renegotiating or exiting those agreements have in several instances exceeded the original capital value.
Opposition MPs and health watchdogs have characterised the new programme as PFI in a revised form, and have raised concerns that reintroducing private finance carries the same structural risks regardless of the label applied to it. The central objection is that private capital requires a return, and that return is ultimately met through long-term lease or service payments that constrain the financial flexibility of the NHS organisations occupying the buildings. Where those payments are set at rates that made commercial sense at the time of signing but prove difficult to sustain over decades of changing NHS funding settlements, the consequences fall on local services rather than on the investors.
Primary care leaders have expressed specific concern about the rental cost implications for GP practices expected to operate from privately financed buildings. If lease costs are set at levels that reflect the commercial terms required to attract investment, they may absorb a disproportionate share of the funding available to individual practices, reducing what is available for staffing and direct patient care. That concern is not theoretical. It reflects the documented experience of a number of practices that operated under NHS LIFT arrangements and found the financial terms difficult to manage within standard primary care funding envelopes.
The government's position is that the alternative, relying solely on public capital, would mean either a significantly slower delivery programme or a direct competition with other NHS capital priorities, including the long-delayed hospital building programme. Ministers have argued that private investment is not a preferred option but a practical one given the fiscal position, and that the advisory work being commissioned is specifically intended to produce a model that protects NHS occupants from the contractual rigidities that characterised earlier schemes.
Whether that objective is achievable depends on the terms Deloitte and Addleshaw Goddard are able to design and the extent to which those terms prove attractive to the private investors the programme requires. A model sufficiently protective of the public interest to satisfy critics may not generate the returns necessary to draw institutional capital at the volume and pace the timetable demands. That tension sits at the centre of the advisory work now underway, and its resolution will determine whether the neighbourhood health centre programme proceeds as planned or contracts in ambition as the financial realities of the model become clearer.
